Skip to main content
OICS v0.4.1 class · Healthcare

Branded Prescription Drugs

ID RXB HC.PH.PHA.RXB

Discovers, develops and markets branded prescription medicines or vaccines with approved products in at least three therapeutic areas, for humans or animals; a company moves between this class and Commercial Biotech only after two consecutive annual reports on the other side.

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.PHA Pharmaceuticals in the standard Selling approved medicines at scale.

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

Counted by primary class: every company classified here, including delisted companies and companies without filings.

Company Ticker Country Market cap Filings
ELI LILLY & Co LLY United States of America $1042.60Bas of 17 Jul 2026 4,147
Johnson & Johnson JNJ United States of America $609.12Bas of 20 Jul 2026 3,366
AbbVie Inc. ABBV United States of America $449.63Bas of 20 Jul 2026 2,223
Roche Holding AG RO Switzerland $320.02Bas of 21 Jul 2026 480
Novartis AG NOVN Switzerland $286.07Bas of 1 Jul 2026 1,772
AstraZeneca PLC AZN United Kingdom $250.90Bas of 15 Jul 2026 3,726
Amgen Inc. AMGN United States of America $198.61Bas of 9 Jul 2026 3,187
Gilead Sciences, Inc. GILD United States of America $169.23Bas of 31 Mar 2026 3,121
Pfizer Inc. PFE United States of America $156.83Bas of 28 Mar 2026 6,737
BRISTOL MYERS SQUIBB CO BMY United States of America $117.58Bas of 13 Jul 2026 3,651
VERTEX PHARMACEUTICALS INC / MA VRTX United States of America $112.56Bas of 31 Mar 2026 3,565
GSK plc GSK United Kingdom $112.14Bas of 7 Apr 2026 7,418
Sanofi SAN France $101.52Bas of 20 Jul 2026 4,802
REGENERON PHARMACEUTICALS, INC. REGN United States of America $81.68Bas of 2 Apr 2026 2,433
CHUGAI PHARMACEUTICAL CO., LTD. 4519 Japan $75.74B 855
Takeda Pharmaceutical Company Limited 4502 Japan $69.71B 2,294
Merck & Co., Inc. MRK United States of America $65.78Bas of 11 Jun 2026 2,342
Galderma Group AG GALD Switzerland $47.90Bas of 13 Jul 2026 49
Otsuka Holdings Co., Ltd. 4578 Japan $41.32B 741
DAIICHI SANKYO COMPANY, LIMITED 4568 Japan $32.22B 1,108
Zoetis Inc. ZTS United States of America $32.10Bas of 20 Jul 2026 2,194
Royalty Pharma plc RPRX United Kingdom $32.03Bas of 11 Jun 2026 734
Astellas Pharma Inc. 4503 Japan $31.37B 1,337
BIOGEN INC. BIIB United States of America $26.97Bas of 2 Apr 2026 2,654
UNITED THERAPEUTICS Corp UTHR United States of America $23.22Bas of 2 Jul 2026 4,294
Shionogi & Co.,Ltd. 4507 Japan $17.69B 1,327
Jazz Pharmaceuticals plc JAZZ Ireland $15.53Bas of 20 Jul 2026 2,028
Ipsen IPN France $15.30Bas of 1 Jul 2026 1,589
Swedish Orphan Biovitrum SOBI Sweden $13.39Bas of 8 Apr 2026 1,090
Elanco Animal Health Inc ELAN United States of America $12.55Bas of 7 Jul 2026 1,130
Ionis Pharmaceuticals, Inc. IONS United States of America $12.35Bas of 4 Apr 2026 2,648
BIOMARIN PHARMACEUTICAL INC BMRN United States of America $10.92Bas of 24 Jun 2026 2,709
Orion Oyj ORNAV Finland $10.84Bas of 29 Jun 2026 1,261
Kyowa Kirin Co.,Ltd. 4151 Japan $8.45B 665
ONO PHARMACEUTICAL CO., LTD. 4528 Japan $7.82B 575
PTC THERAPEUTICS, INC. PTCT United States of America $5.34Bas of 15 Mar 2026 1,368
Sumitomo Pharma Co., Ltd. 4506 Japan $5.33B 1,071
LIGAND PHARMACEUTICALS INC LGND United States of America $3.98Bas of 5 Apr 2026 2,090
Almirall S.A. ALM Spain $2.92Bas of 8 Apr 2026 305
Faes Farma S.A. FAE Spain $1.58Bas of 24 Jun 2026 223
Nippon Shinyaku Co.,Ltd. 4516 Japan $1.49B 367
KISSEI PHARMACEUTICAL CO.,LTD. 4547 Japan $1.30B 621
KAKEN PHARMACEUTIAL CO., LTD. 4521 Japan $1.05B 628
DAEWOONG PHARMA 069620 South Korea $1.02Bas of 16 Jul 2026 1,316
Mochida Pharmaceutical Co.,Ltd. 4534 Japan $766.54M 619
DAEWOONG CO.,LTD 003090 South Korea $759.69Mas of 22 Mar 2026 1,632
CorMedix Inc. CRMD United States of America $659.00Mas of 13 Jul 2026 1,094
ZERIA PHARMCEUTICAL CO., LTD. 4559 Japan $651.64M 543
KYORIN Pharmaceutical Co., Ltd. 4569 Japan $412.78M 639
JCR Pharmaceuticals Co.,Ltd. 4552 Japan $401.04M 1,138

Companies in Pharmaceuticals → Open in the screener →

Other names for this activity, and where neighboring activities go instead.

Also known as

big pharmainnovative pharmaceuticalsanimal health

Not here
Generics & Consumer Health GNX HC.PH.PHA.GNX

Makes generic or biosimilar medicines, off-patent or reformulated specialty drugs, over-the-counter and consumer-health products (including vitamins, dietary supplements and medical nutrition), active ingredients, or compounded drugs, for humans or animals; a drugmaker goes by what earns most, its own patented medicines or the rest. For a company with approved products on the market, whether a medicine is its own patented medicine depends on the active substance: a new molecular entity or new biologic, discovered, in-licensed or acquired, is a patented medicine; a new formulation, dosage form, delivery system or combination of an already approved substance is a reformulated specialty drug (here) even when the formulation is patented, and so are plasma-derived proteins and traditional or herbal medicines. A drug developer with no approved medicine on the market -> HC.PH.BIO.CLB, whatever it develops.

Also generics, OTC, API manufacturer, biosimilars

https://financialfilings.com/oics/RXB/

This page is keyed by the class ID RXB. IDs freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard